about
Medullary thyroid carcinoma: targeted therapies and future directionsCabozantinib for the treatment of metastatic medullary thyroid carcinomaRET mutations in a large indian family with medullary thyroid carcinoma.Painful Hip Leading to the Diagnosis of MEN 2B Syndrome.Exomic sequencing of medullary thyroid cancer reveals dominant and mutually exclusive oncogenic mutations in RET and RAS.Pediatric Medullary Thyroid CarcinomaGlucagon-Like Peptide-1 Receptor Imaging with [Lys (40) (Ahx-HYNIC- (99 m) Tc/EDDA)NH 2 ]-Exendin-4 for the Diagnosis of Recurrence or Dissemination of Medullary Thyroid Cancer: A Preliminary Report.Regulation of cell-cell contact molecules and the metastatic phenotype of medullary thyroid carcinoma by the Raf-1/MEK/ERK pathway.¹⁸F-FDG-PET and ¹⁸F-FDG-PET/CT in the detection of recurrent or metastatic medullary thyroid carcinoma: a systematic review and meta-analysis.Lentivirus-mediated silencing of MPHOSPH8 inhibits MTC proliferation and enhances apoptosis.Thiocoraline alters neuroendocrine phenotype and activates the Notch pathway in MTC-TT cell line.Metastatic medullary thyroid carcinoma: A case report.Survival implications of cervical lymphadenectomy in patients with medullary thyroid cancer.Acute liver failure secondary to metastatic medullary thyroid cancer.Metastatic Medullary Thyroid Carcinoma and Cabozantinib: Case Series and Review of Literature.Genes of detoxification are important modulators of hereditary medullary thyroid carcinoma risk.Educational Case: Endocrine Neoplasm: Medullary Thyroid Carcinoma.
P2860
Q33557376-8EEEDD6A-BE78-4C95-8AC1-F4643E4709D0Q33886147-5A72C80A-4222-47CF-8E2F-CE2705A40958Q34069272-F606D7C1-1D9B-4B94-BEA4-40AD5D285DB9Q36443158-013CEE2B-E358-4853-B618-A7C2D0F5911EQ36589374-A8AC3543-7C11-48A5-8B47-85A6A292D8FBQ36715586-34CF977B-729C-4205-8882-FA13AFADE46AQ36765871-3712DB23-BCF0-4CBC-87A2-63890EEAC3B1Q37091159-9E170A0C-C92E-4FF4-9B43-84D5DD941273Q38002184-EB807CA2-C12B-4DA8-B380-35251DE51D16Q38763963-849B7A75-3DC1-4D45-9FF9-C9AB7AD588DDQ39036247-E39AF842-D3BF-4F0F-A20C-D7F3AEB7A935Q39049898-9EC46631-2E8D-4795-8D7D-848AFA19C6EFQ39821042-95B2F391-BA4E-47BE-9B3E-ED66432C3167Q40007303-04702AA3-4C9F-4877-A739-A0C94AAB1050Q47137441-E95271BC-55E3-4B3D-A779-406BCB45B7A5Q50883381-7B21FF00-AF42-436D-ABBF-BB09797D82C5Q55491526-230166FF-CECA-43E4-B8B4-7202B761AD1D
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Medullary thyroid cancer: monitoring and therapy.
@ast
Medullary thyroid cancer: monitoring and therapy.
@en
type
label
Medullary thyroid cancer: monitoring and therapy.
@ast
Medullary thyroid cancer: monitoring and therapy.
@en
prefLabel
Medullary thyroid cancer: monitoring and therapy.
@ast
Medullary thyroid cancer: monitoring and therapy.
@en
P2860
P1476
Medullary thyroid cancer: monitoring and therapy.
@en
P2093
Douglas W Ball
P2860
P304
823-37, viii
P356
10.1016/J.ECL.2007.04.001
P577
2007-09-01T00:00:00Z